Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Applied Optics|January 14, 2005
Scattering phase function measurements on single particles and on particle ensemblesAlessandro Rossi, Laura Botti, Christian Sasse, et al.Journal of Experimental & Clinical Cancer Research : CR|June 26, 2023
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcomaCaterina Cascini, Chiara Ratti, Laura Botti, et al.Epigenomics|March 26, 2024
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell responseIrene Fischetti, Laura Botti, Roberta Sulsenti, et al.Molecular Cancer|December 12, 2022
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signalingCeleste Rizzello, Valeria Cancila, Sabina Sangaletti, et al.Cancer Research|July 19, 2014
Osteopontin shapes immunosuppression in the metastatic nicheSabina Sangaletti, Claudio Tripodo, Sara Sandri, et al.Oncogene|July 19, 2022
SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine modelMaria Bellenghi, Giovanna Talarico, Laura Botti, et al.Cell Death & Disease|September 30, 2024
Mast cell heparanase promotes breast cancer stem-like features via MUC1/estrogen receptor axisRoberta Bongiorno, Mara Lecchi, Laura Botti, et al.Molecular Cancer Research : MCR|March 3, 2023
JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast CancerBianca Cioni, Silvia Ratti, Annamaria Piva, et al.Iscience|June 18, 2021
SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritisSabina Sangaletti, Laura Botti, Alessandro Gulino, et al.Cancer Research|November 1, 2022
ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer TransformationMilena Perrone, Claudia Chiodoni, Mara Lecchi, et al.Pageof 3